Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a few years ago that its use became mainstream. Originally crafted to help people with type-2 diabetes, the class of medication was quickly recognized as a way to facilitate weight loss. In 2023, celebrities and average joes alike couldn't wait to get their hands on the highly effective injectables in hopes of a lower body fat percentage. ...
